ALEXANDRIA, Va., March 19 -- United States Patent no. 12,251,449, issued on March 18, was assigned to William Marsh Rice University (Houston), Baylor College of Medicine (Houston) and The Board of Regents of The University of Texas System (Austin, Texas).

"Synthetic multidomain peptide biomaterials that inhibit inducible nitric oxide synthase" was invented by Jeffrey Hartgerink (Pearland, Texas), Andrew G. Sikora (Houston), David Leach (Houston), Jared M. Newton (Houston) and Simon Young (Houston).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are compositions comprising multi domain peptide (MDP) hydrogels where the peptides that constitute the hydrogel have at least one N6-(1-iminoethyl)-lys...